Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
复制标题
DOI：
10.2337/dci19-0028
复制
发表时间：
2019-08-01
期刊：
影响因子：
16.2
通讯作者：
Phillip, Moshe
中科院分区：
文献类型：
--
作者：
Battelino, Tadej;Danne, Thomas;Phillip, Moshe
传感器准确性的提高、更大的便利性和易用性以及不断扩大的报销范围，使得持续葡萄糖监测（CGM）越来越多地被采用。然而，CGM技术在常规临床实践中的成功利用率仍然相对较低。这可能部分是由于缺乏明确和商定的血糖目标，糖尿病团队和糖尿病患者都可以朝着这个目标努力。虽然在三篇独立的同行评审文章中已经建立了使用关键CGM指标的统一建议，但糖尿病专业组织的正式采用以及这些指标在临床实践中的实际应用指南一直缺乏。2019年2月，糖尿病先进技术与治疗（ATTD）大会召集了一个由CGM技术专家组成的国际专家组，由医生、研究人员和糖尿病患者组成。本文总结了ATTD关于不同糖尿病人群中CGM数据利用和报告相关方面的共识建议。
Improvements in sensor accuracy, greater convenience and ease of use, and expanding reimbursement have led to growing adoption of continuous glucose monitoring (CGM). However, successful utilization of CGM technology in routine clinical practice remains relatively low. This may be due in part to the lack of clear and agreed-upon glycemic targets that both diabetes teams and people with diabetes can work toward. Although unified recommendations for use of key CGM metrics have been established in three separate peer-reviewed articles, formal adoption by diabetes professional organizations and guidance in the practical application of these metrics in clinical practice have been lacking. In February 2019, the Advanced Technologies & Treatments for Diabetes (ATTD) Congress convened an international panel of physicians, researchers, and individuals with diabetes who are expert in CGM technologies to address this issue. This article summarizes the ATTD consensus recommendations for relevant aspects of CGM data utilization and reporting among the various diabetes populations.